Information  X 
Enter a valid email address

Lipoxen PLC (XEN)

  Print      Mail a friend

Monday 20 July, 2009

Lipoxen PLC

Director Shareholding

RNS Number : 9421V
Lipoxen PLC
20 July 2009
 



Lipoxen plc 

('Lipoxen' or the 'Company')


Director dealings


The Company was informed on 20 July 2009 that FDS Pharma ('FDS') disposed of 300,00ordinary shares of 0.5p each ('Ordinary Shares') at 11 pence each on 20 July 2009


FDS director and partner Dr Dimitry D. Genkin is non-executive directors of Lipoxen. Following this disposal he, through FDS, has an interest in Lipoxen of 42,455,316 Ordinary Shares, representing 27.56 per cent of the issued Ordinary Share capital in the Company.


Enquires:


Lipoxen plc

+44 (0)20 7691 3583 

M. Scott Maguire, Chief Executive Officer




Singer Capital Markets (nominated adviser)

+44 (0)20 3205 7500

Jeff Keating / Claes Spång 




Noble & Company

+44 (0) 20 7763 2200 

John Llewellyn-Lloyd / Sam Reynolds  




Buchanan Communications

+44 (0)20 7466 5000

Mary-Jane Elliott, Lisa Baderoon, Rebecca Skye Dietrich, Catherine Breen




This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSCKKKDKBKDQOB